Welcome to our dedicated page for PURR news (Ticker: PURR), a resource for investors and traders seeking the latest updates and insights on PURR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PURR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PURR's position in the market.
Hyperliquid Strategies (NASDAQ: PURR) announced a $30 million stock repurchase program authorized by its Board of Directors on Dec 8, 2025.
The program may run for up to 12 months and allows repurchases in open‑market or privately negotiated transactions at prevailing market prices, subject to federal securities laws. Management will decide timing, number and value of repurchases at its discretion.
The company said it intends to use cash to increase shareholders' per‑share exposure to HYPE, the native token of the Hyperliquid ecosystem. There is no guaranteed number of shares to be repurchased; the program may be extended, suspended, or discontinued without notice.
